The Certara Blog

Author: Steve Toon

Dr Stephen Toon is the Managing Director of Certara's Simcyp business unit. Steve received his pharmacy degree from the University of Bath and his PhD in pharmacokinetics from the University of Manchester. following a period at the University of Washington, he founded Medeval, a clinical pharmacology CRO, which was acquired by ICON in 2003. He has published over 50 articles, abstracts and chapters in books.

Recent Posts

Status of QSP Modeling in the Pharmaceutical Industry

A primary cause of failures in pharmaceutical research and development (R&D) has been attributed to lack of efficacy,1 suggesting inadequate understanding in therapeutic targets’ biology and their relevance to disease progression or modulation. Quantitative systems pharmacology (QSP) has the promise of increasing the probability of success in R&D by bridging scientific gaps between disciplines to enable […]

Read More

How to Optimize Your Drug Label Using Biosimulation Technology

As a trained pharmacist and scientist, I think a lot about patient care and how the drug development process impacts drug labels and the clinical use of medicines. Biosimulation technology encompasses methods such as physiologically based pharmacokinetic (PBPK) models. PBPK provides insight into drug mechanisms. It also helps clinicians provide the safest and most effective […]

Read More
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog